Frontier Bio creates lab-grown human tissues to reduce reliance on animal testing and to eliminate the organ transplant waitlist. We're starting with blood vessels and have excellent results in our first preclinical implantation study.

Key Highlights:
• $5.5M cumulative sales
• Backed by a Nobel Laureate
• $3.9M prior funding + NSF SBIR grant
• Profitable last year